The effects of BMP-2 gene medication on the reconstruction of osteolytic bone defect around implant

Meng-ning YAN,Ke-rong DAI,Ting-ting TANG

DOI: https://doi.org/10.3321/j.issn:1001-9030.2008.06.007

2008-01-01

Abstract:Objective With the osteolystic model,the simulating revision was done to investigate the effects of BMP-2 gene therapy on the reconstruction of periprosthetic bone defect.Methods A 3 mm bone defect around Ti alloy implant was created in both femoral lateral condyla of 6 adult Beagle dogs.One animal was left as a model to evaluate the effects of particles on the defect,with 1 ml Ti alloy particles averaged diameter of 1μm implanted on the left bone defect and 1 ml PBS on the right.Ten defects of the other 5 animals were implanted 1 ml Ti alloy particle and the revisions were done 2 months postoperatively.With the impaction grafting technique,two defects of each animal were reconstructed with freeze-dried allograft (FDB group),freeze-dried allograft loading autogenous bone marrow stromal cells transfected by Adv-BMP2 gene (gene group) respectively.The allograft healing and osseointegration of bone-implant interface were evaluated by histological,histomorphometric methods at 3rd month after revision.Results Histologically,at 2nd month,the loose osteolytic membrane tissue was typical found on the defect with particles.Three months after revision,there were many graft remnants and new bone formation in the defects in FDB group.In gene group,there were little graft remnants and many new bone remodeling.Histomorphometrically,most of the interface was connective fibrous tissue in FDB group and the bone-implant contact (BIC) ratio was (1.38±1.22)%.In gene group,point bone-implant contact was found and the BIC was (12.96±1.61)%,significantly higher than that in FDP group (P<0.01).Conclusion BMP-2 gene therapy can improve the osseointegration of bone-implant interface in the osteolytic defect around implant.